|
SEPT7P2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.077400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.725000E-01 |
| Normal-vs-Stage2 |
3.192600E-01 |
| Normal-vs-Stage3 |
3.554600E-01 |
| Normal-vs-Stage4 |
2.727200E-01 |
| Stage1-vs-Stage2 |
6.097200E-01 |
| Stage1-vs-Stage3 |
3.012400E-02 |
| Stage1-vs-Stage4 |
1.653510E-02 |
| Stage2-vs-Stage3 |
1.387850E-01 |
| Stage2-vs-Stage4 |
8.790000E-02 |
| Stage3-vs-Stage4 |
6.873200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.751000E-01 |
| Normal-vs-AfricanAmerican |
2.126600E-01 |
| Normal-vs-Asian |
2.595800E-01 |
| Caucasian-vs-AfricanAmerican |
5.629800E-01 |
| Caucasian-vs-Asian |
5.443800E-01 |
| AfricanAmerican-vs-Asian |
7.452800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.037400E-01 |
| Normal-vs-Female |
3.523000E-01 |
| Male-vs-Female |
8.513800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.752000E-01 |
| Normal-vs-Extreme_Weight |
2.716400E-01 |
| Normal-vs-Obese |
3.186000E-01 |
| Normal-vs-Extreme_Obese |
5.842800E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.702800E-01 |
| Normal_Weight-vs-Obese |
4.036600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.368800E-01 |
| Extreme_Weight-vs-Obese |
9.557400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.215200E-01 |
| Obese-vs-Extreme_Obese |
3.230200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.538440E-01 |
| Normal-vs-Age(41-60Yrs) |
9.062300E-02 |
| Normal-vs-Age(61-80Yrs) |
4.730600E-01 |
| Normal-vs-Age(81-100Yrs) |
8.241400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.323600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.369400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.759600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.961780E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.377600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.149800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.236900E-03 |
| Normal-VS-Type2 PRCC |
9.420300E-03 |
| Normal-VS-KIRP CIMP |
4.776000E-01 |
| Normal-VS-Unclassified PRCC |
5.941400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.37498909427813E-12 |
| Type1 PRCC-VS-KIRP CIMP |
5.293800E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.557800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.965600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.583860E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.933400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.748400E-01 |
| Normal-vs-N1 |
8.311800E-01 |
| Normal-vs-N2 |
3.330800E-01 |
| N0-vs-N1 |
8.639200E-01 |
| N0-vs-N2 |
5.283000E-01 |
| N1-vs-N2 |
4.194400E-01 |
|
|
